Conservative therapeutical regime in chronic venous ulcers of lower limb adapted to clinical findings;Konservative befundadaptierte therapie von superinfizierten chronischen venös bedingten ulcera cruris

Vasa - Journal of Vascular Diseases

Volumn 33, Issue 2, 2004, Pages 97-101

  Billmann, M K ^a   Kohler Ch ^a   Varelas, X ^a   Mayer, Dieter ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Chronic venous ulcer of lower limb; Conservative wound management; Moist wound healing dressing; Oxidised regenerated cellulose

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT;

AGED; ANALGESIA; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CHRONIC VEIN INSUFFICIENCY; CHRONIC VENOUS ULCER; COMPRESSION THERAPY; CONSERVATIVE TREATMENT; DEBRIDEMENT; HIGH RISK PATIENT; HUMAN; INFLAMMATION; MALE; MEDICAL DOCUMENTATION; MORBIDITY; PAIN ASSESSMENT; SAPHENOUS VEIN; SCORING SYSTEM; SKIN ULCER; SUPERINFECTION; TREATMENT CONTRAINDICATION; ULCER; VEIN INSUFFICIENCY; WOUND CARE; WOUND DRESSING; WOUND HEALING;

EID: 2642517831     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.33.2.97     Document Type: Article

References (11)

1. Baker SR, Stacey MC, Jopp-McKay AG, Hoskin SE, Thompson PJ. Epidemiology of chronic venous ulcers. Br J Surg 1991; 78 (7): 864-7.
2. Barwell JR, Taylor M, Deacon J, Ghauri AS, Wakely C, Phillips LK, Whyman MR, Poskitt KR. Surgical correction of isolated superficial venous reflux reduces long-term recurrence rate in chronic venous leg ulcers. Eur J Vasc Endovasc Surg. 2000; 20 (4): 363-8.
3. Cullen B, Smith R, McCulloch E, Silcock D, Morrison L. Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Rep Reg 2002; 10: 16-25.
4. Fowkes FG, Evans CJ, Lee AJ. Prevalence and risk factors of chronic venous insufficiency. Angiology 2001; 52 Suppl 1: 5-15.
5. Gillitzer R. Modernes Wundmanagement. Hautarzt 2002; 53: 130-47.
6. Ladwig GP, Robson MC, Liu R, Kuhn A, Muir DF, Schultz GS. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Rep Reg 2002; 10: 26-37.
7. Marston WA, Carlin RE, Passmann MA, Farber MA, Keagy BA. Healing rates and cost efficacy of outpatient compression treatment for leg ulcers associated with venous insufficiency. J Vasc Surg 1999; 30: 491-8.
8. Schmidt K, Debus ES, Jessberger S, Ziegler U, Thiede A. Bacterial population of chronic crural ulcers: is there a difference between the diabetic, the venous and the arterial ulcer? VASA 2000; 29: 62-70.
9. Scriven JM, Hartshorne T, Thrush AJ, Bell PR, Naylor AR, London NJ. Role of saphenous vein surgery in the treatment of venous ulceration. Br J Surg 1998; 85: 781-4.
10. Seiler WO. Die Feuchttherapie - ein Meilenstein in der Behandlung chronischer Ulzera. HARTMANN WundForum 2000; 2: 14-6.
11. Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F, Murphy G, Schultz G. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Rep Reg 1999; 7 (6): 442-52.